HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Belma Turan Selected Research

Sodium Selenite

7/2006Sodium selenite protects against diabetes-induced alterations in the antioxidant defense system of the liver.
9/2005Selenium improves cardiac function by attenuating the activation of NF-kappaB due to ischemia-reperfusion injury.
3/2005Beneficial effects of selenium on some enzymes of diabetic rat heart.
2/2005Selenium-induced alterations in ionic currents of rat cardiomyocytes.
1/2005Selenium treatment protects diabetes-induced biochemical and ultrastructural alterations in liver tissue.
6/2004Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat.
12/2003Selenium combined with vitamin E and vitamin C restores structural alterations of bones in heparin-induced osteoporosis.
12/2002Protective effect of selenium treatment on diabetes-induced myocardial structural alterations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Belma Turan Research Topics

Disease

14Hyperglycemia
05/2022 - 12/2009
13Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2022 - 08/2014
13Body Weight (Weight, Body)
06/2021 - 06/2002
12Diabetic Cardiomyopathies
01/2022 - 12/2002
11Insulin Resistance
11/2022 - 11/2017
5Ischemia
01/2022 - 08/2005
4Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 11/2019
4Reperfusion Injury
01/2020 - 02/2005
4Cardiovascular Diseases (Cardiovascular Disease)
10/2014 - 02/2007
3Heart Failure
11/2022 - 01/2005
3Cardiac Arrhythmias (Arrythmia)
06/2021 - 03/2014
3Hypertrophy
01/2019 - 10/2014
2Dyslipidemias (Dyslipidemia)
11/2020 - 12/2018
2Diabetes Mellitus
01/2020 - 01/2003
2Left Ventricular Dysfunction
01/2020 - 11/2017
2Fibrosis (Cirrhosis)
06/2019 - 10/2014
2Overweight
11/2018 - 11/2017
2Cardiomyopathies (Cardiomyopathy)
07/2015 - 01/2005
2Heart Diseases (Heart Disease)
01/2013 - 12/2007
2Diabetes Complications
01/2005 - 12/2002
1Glucose Intolerance
11/2022
1Cardiotoxicity
01/2021
1Inflammation (Inflammations)
11/2020
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2020
1Abdominal Obesity
12/2018
1Hypoxia (Hypoxemia)
04/2018
1Obesity
11/2017
1Cardiomegaly (Heart Hypertrophy)
11/2017
1Disease Progression
10/2017
1Kidney Diseases (Kidney Disease)
10/2014
1Microvascular Rarefaction
08/2014
1Diabetic Nephropathies (Diabetic Nephropathy)
05/2014

Drug/Important Bio-Agent (IBA)

15Streptozocin (Streptozotocin)FDA Link
04/2018 - 06/2004
10Insulin (Novolin)FDA Link
11/2022 - 12/2002
10Blood Glucose (Blood Sugar)IBA
06/2021 - 06/2002
10AntioxidantsIBA
01/2018 - 01/2005
8Sodium SeleniteIBA
07/2006 - 12/2002
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2005
6Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2007
5Glucose (Dextrose)FDA LinkGeneric
11/2020 - 05/2014
5SeleniumIBA
02/2007 - 06/2002
4Matrix Metalloproteinases (MMPs)IBA
05/2022 - 12/2009
4CarbohydratesIBA
01/2022 - 11/2017
4Timolol (Blocadren)FDA LinkGeneric
07/2019 - 10/2014
4Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2016 - 10/2011
3TicagrelorIBA
05/2022 - 06/2020
3Sucrose (Saccharose)IBA
12/2018 - 10/2016
3Glutathione Transferase (Glutathione S-Transferase)IBA
10/2014 - 01/2005
3Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
10/2014 - 01/2005
3Selenic AcidIBA
05/2011 - 01/2008
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
2Trace Elements (Biometals)IBA
11/2020 - 09/2005
2Sodium-Glucose Transporter 2 InhibitorsIBA
06/2019 - 11/2018
2dapagliflozinIBA
06/2019 - 11/2018
2Drinking WaterIBA
11/2017 - 10/2016
2Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
10/2014 - 01/2005
2EnzymesIBA
10/2014 - 01/2005
2Oxidants (Oxidizing Agents)IBA
01/2013 - 12/2009
2Glutathione (Reduced Glutathione)IBA
06/2011 - 03/2005
2Doxycycline (Periostat)FDA LinkGeneric
06/2011 - 05/2011
2Glutathione PeroxidaseIBA
09/2005 - 01/2005
2Phosphogluconate Dehydrogenase (Dehydrogenase, Phosphogluconate)IBA
03/2005 - 01/2005
1Cardiotonic Agents (Cardiac Stimulants)IBA
11/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2022
1Therapeutic UsesIBA
11/2022
1Connexin 43 (Connexin43)IBA
01/2022
1LiraglutideFDA Link
01/2022
1Glucagon-Like Peptide-1 ReceptorIBA
01/2022
1LipidsIBA
06/2021
1CholesterolIBA
06/2021
1CytokinesIBA
06/2021
1Triglycerides (Triacylglycerol)IBA
06/2021
1sibutramine (Meridia)FDA Link
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Palmitic Acid (Hexadecanoic Acid)IBA
06/2020
1SodiumIBA
01/2020
1Ion Channels (Ion Channel)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1SymportersIBA
01/2020
1ConnectinIBA
01/2020
1PalmitatesIBA
11/2019
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2019
1N- (2- (2- (4- chlorophenyl)- 1,3- thiazol- 4- yl)ethyl)butanamideIBA
11/2019
1Sodium-Glucose Transport ProteinsIBA
06/2019
1ThiazolidinedionesIBA
12/2018
1Pioglitazone (Actos)FDA Link
12/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2018
1fasudil (AT 877)IBA
11/2017
1Cyclic AMP (AMP, Cyclic)IBA
11/2017
1rho-Associated KinasesIBA
11/2017
1Reactive Nitrogen SpeciesIBA
02/2016
1Adrenergic Receptors (Adrenergic Receptor)IBA
07/2015
1CatecholaminesIBA
12/2014
1Adrenergic Agents (Adrenergic Drugs)IBA
10/2014
1Free RadicalsIBA
10/2014
1GlycogenIBA
10/2014
1Sitagliptin Phosphate (Januvia)FDA Link
08/2014
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2014
1IncretinsIBA
08/2014

Therapy/Procedure

5Therapeutics
01/2019 - 12/2002